RESUMEN

A patient with advanced multiple myeloma (MM) and renal failure presented a severe chronic anemia requiring frequent blood transfusions. Treatment with recombinant human erythropoietin (rHuEPO) led to a rapid improvement of anemia, and further blood transfusions were not required. Pathophysiological studies about the erythropoiesis in patients with MM and trials with rHuEPO in myeloma-associated anemia are commented.

Asunto(s)

Anemia/tratamiento farmacológico , Eritropoyetina/uso terapéutico , Fallo Renal Crónico/complicaciones , Mieloma Múltiple/complicaciones , Anciano , Anemia/etiología , Enfermedad Crónica , Terapia Combinada , Resultado Fatal , Femenino , Humanos , Cadenas kappa de Inmunoglobulina , Fallo Renal Crónico/terapia , Mieloma Múltiple/terapia , Proteínas Recombinantes/uso terapéutico